We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,832 results
  1. Cerebrospinal Fluid CXCL13 as Candidate Biomarker of Intrathecal Immune Activation, IgG Synthesis and Neurocognitive Impairment in People with HIV

    Plasma C-X-C-motif chemokine ligand-13 (CXCL13) has been linked to disease progression and mortality in people living with HIV (PLWH) and is a...

    Mattia Trunfio, Lorenzo Mighetto, ... Andrea Calcagno in Journal of Neuroimmune Pharmacology
    Article 11 May 2023
  2. Long non-coding RNA maternally expressed gene 3, miR-125a-5p, CXCL13, and NF-kB in patients with immune thrombocytopenia

    The main aim of this study was to assess the expression level of circulating long non-coding RNA maternally expressed gene 3 (lncRNA-MEG3), microRNA...

    Mervat Naguib, Shereen El Sawy, ... Marwa Abdelgwad in Genes & Immunity
    Article Open access 12 April 2023
  3. CXCL13 contributes to chronic pain of a mouse model of CRPS-I via CXCR5-mediated NF-κB activation and pro-inflammatory cytokine production in spinal cord dorsal horn

    Background

    Complex regional pain syndrome type-I (CRPS-I) causes excruciating pain that affect patients’ life quality. However, the mechanisms...

    Jie Wang, Chengyu Yin, ... Boyi Liu in Journal of Neuroinflammation
    Article Open access 08 May 2023
  4. CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis

    Several biomarkers from multiple sclerosis (MS) patients’ biological fluids have been considered to support diagnosis, predict disease course, and...

    Matteo Lucchini, Valeria De Arcangelis, ... Massimiliano Mirabella in Molecular Neurobiology
    Article Open access 10 October 2022
  5. CXCL13 in laboratory diagnosis of Lyme neuroborreliosis—the performance of the recomBead and ReaScan CXCL13 assays in human cerebrospinal fluid samples

    The chemokine CXCL13 is used as complement to serology in the diagnostics of Lyme neuroborreliosis (LNB). We evaluated and compared the...

    Sofie Haglund, Malin Lager, ... Anna J. Henningsson in European Journal of Clinical Microbiology & Infectious Diseases
    Article Open access 09 October 2021
  6. Multiplex Assessment of Serum Chemokines CCL2, CCL5, CXCL1, CXCL10, and CXCL13 Following Traumatic Brain Injury

    Chemokines may promote neuroinflammation following traumatic brain injury (TBI), thereby exacerbating secondary injury. This study was designed to...

    Yuwen Chen, Ying Wang, ... Su Liu in Inflammation
    Article 15 August 2022
  7. CXCL13 Signaling in the Tumor Microenvironment

    Chemokines have emerged as important players in tumorigenic process. An extensive body of literature generated over the last two or three decades...
    Muzammal Hussain, **song Liu, ... Guang-Biao Zhou in Tumor Microenvironment
    Chapter 2021
  8. M2 macrophages secrete CXCL13 to promote renal cell carcinoma migration, invasion, and EMT

    Objective

    M2 macrophages are associated with a poor prognosis in a variety of malignancies. There are, however, few relevant investigations in clear...

    Yingwei **e, Zhiliang Chen, ... Wenlian **e in Cancer Cell International
    Article Open access 18 December 2021
  9. CXCL13 is expressed in a subpopulation of neuroendocrine cells in the murine trachea and lung

    The conducting airways are lined by distinct cell types, comprising basal, secretory, ciliated, and rare cells, including ionocytes, solitary...

    Wafaa Mahmoud, Alexander Perniss, ... Wolfgang Kummer in Cell and Tissue Research
    Article Open access 11 November 2021
  10. Are CSF CXCL13 concentrations solely dependent on intrathecal production? A commentary on “Chemokine CXCL13 in serum, CSF, and blood–CSF barrier function”

    Pilz et al. (Fluids Barriers CNS 17:7; 2020) investigated how CSF CXCL13 concentrations are influenced by CXCL13 serum concentrations and blood-CSF...

    Krista D. DiSano, Francesca Gilli, Andrew R. Pachner in Fluids and Barriers of the CNS
    Article Open access 25 February 2021
  11. CXCL13 expressed on inflamed cerebral blood vessels recruit IL-21 producing TFH cells to damage neurons following stroke

    Background

    Ischemic stroke is a leading cause of mortality worldwide, largely due to the inflammatory response to brain ischemia during post-stroke...

    Aditya Rayasam, Julie A. Kijak, ... Zsuzsanna Fabry in Journal of Neuroinflammation
    Article Open access 27 May 2022
  12. Repopulated microglia induce expression of Cxcl13 with differential changes in Tau phosphorylation but do not impact amyloid pathology

    Background

    Adult microglia rely on self-renewal through division to repopulate and sustain their numbers. However, with aging, microglia display...

    Berke Karaahmet, Linh Le, ... M. Kerry O’Banion in Journal of Neuroinflammation
    Article Open access 04 July 2022
  13. The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF

    Background

    C-X-C chemokine ligand 13 (CXCL13) is frequently elevated in cerebrospinal fluid (CSF) in a variety of inflammatory central nervous system...

    Christine Harrer, Ferdinand Otto, ... Andrea Harrer in Fluids and Barriers of the CNS
    Article Open access 26 August 2021
  14. Harnessing CXCL13 in ovarian cancer

    Elena Brenna, Isabela Pedroza-Pacheco in Nature Reviews Immunology
    Article 27 January 2022
  15. Downregulating lncRNA PVT1 Relieves Astrocyte Overactivation Induced Neuropathic Pain Through Targeting miR-186-5p/CXCL13/CXCR5 Axis

    Spinal cord injury (SCI) is one of the main causes leading to neuropathic pain. Here, we aim to explore the molecular mechanism and function of...

    Peisong Zhang, Hanyu Sun, Zhengang Ji in Neurochemical Research
    Article 19 March 2021
  16. Chemokine CXCL13 acts via CXCR5-ERK signaling in hippocampus to induce perioperative neurocognitive disorders in surgically treated mice

    Background

    Perioperative neurocognitive disorders (PNDs) occur frequently after surgery and worsen patient outcome. How C-X-C motif chemokine (CXCL)...

    Yanan Shen, Yuan Zhang, ... Yanna Si in Journal of Neuroinflammation
    Article Open access 08 November 2020
  17. CXCL13 Is Involved in the Lipopolysaccharide-Induced Hyperpermeability of Umbilical Vein Endothelial Cells

    Sepsis is a disease that is characterized by a severe systemic inflammatory response to microbial infection and lipopolysaccharide (LPS) and is a...

    Wen Chen, Yi Wang, ... **hong Wu in Inflammation
    Article Open access 04 June 2020
  18. The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study

    The role of CXCL13 as a marker of Lyme neuroborreliosis (LNB) is under investigation, and CXCL13 is not part of routine diagnostics in suspicion of...

    Fredrikke Christie Knudtzen, Anna Christine Nilsson, ... Sigurdur Skarphedinsson in European Journal of Clinical Microbiology & Infectious Diseases
    Article 14 March 2020
  19. Chemokine CXCL13 in serum, CSF and blood–CSF barrier function: evidence of compartment restriction

    Background and purpose

    Elevation of the chemokine CXCL13 in CSF frequently occurs during active and acute CNS inflammatory processes and presumably is...

    Georg Pilz, Irma Sakic, ... Andrea Harrer in Fluids and Barriers of the CNS
    Article Open access 24 February 2020
  20. Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma

    Despite no apparent defects in T cell priming and recruitment to tumors, a large subset of T cell rich tumors fail to respond to immune checkpoint...

    Assaf Magen, Pauline Hamon, ... Miriam Merad in Nature Medicine
    Article 15 June 2023
Did you find what you were looking for? Share feedback.